Rheumatoid arthritis

MTX does not increase risk of ILD in RA patients: study

Suspicions that methotrexate (MTX) may increase the risk of RA-associated interstitial lung disease (ILD) have been allayed by a study showing an inverse association between exposure to the DMARD and the lung disease. Although MTX has been associated with hypersensitivity pneumonitis, its link to ILD in patients with RA has been disputed, according to Dr ...

Already a member?

Login to keep reading.

© 2021 the limbic